Financial statements Przedsiębiorstwo Farmaceutyczne Lekfarm
Balance sheet data of PRZEDSIĘBIORSTWO FARMACEUTYCZNE LEKFARM
|
Year
|
2018
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 8 003 691,63 | 9 085 841,84 | 10 133 823,41 | 11 209 116,93 | 11 863 555,27 |
| A. Fixed assets | 418 445,61 | 527 661,32 | 549 865,52 | 680 068,61 | 1 112 880,46 |
| B. Current assets | 7 585 246,02 | 8 558 180,52 | 9 583 957,89 | 10 529 048,32 | 10 750 674,81 |
| C. Share capital contributions (basic funds) | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - |
| Total liabilities | 8 003 691,63 | 9 085 841,84 | 10 133 823,41 | 11 209 116,93 | 11 863 555,27 |
| A. Equity | 6 629 991,82 | 7 934 385,74 | 8 284 212,51 | 8 952 056,69 | 9 047 441,05 |
| B. Liabilities and provisions for liabilities | 1 373 699,81 | 1 151 456,10 | 1 849 610,90 | 2 257 060,24 | 2 816 114,22 |
| I. Long-term liabilities | - | - | - | - | - |
| II. Short-term liabilities | 1 188 083,37 | 1 011 053,80 | 1 710 281,08 | 2 093 446,81 | 2 589 539,48 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.